Northwest Biotherapeutics, Inc.
NWBO
$0.1901
-$0.0039-2.01%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.18M | 2.94M | 2.88M | 2.48M | 2.13M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.89M | 2.25M | 2.10M | 2.47M | 2.00M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 4.06M | 5.19M | 4.98M | 4.95M | 4.13M |
|
|
|||||
| Total Current Assets | 4.06M | 5.19M | 4.98M | 4.95M | 4.13M |
| Net Property, Plant & Equipment | 20.38M | 21.84M | 20.96M | 21.34M | 21.46M |
| Long-term Investments | 626.00K | 626.00K | 626.00K | 626.00K | 626.00K |
| Goodwill | 626.00K | 626.00K | 626.00K | 626.00K | 626.00K |
| Total Other Intangibles | 1.29M | 1.29M | 1.29M | 1.29M | 1.29M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 365.00K | 374.00K | 372.00K | 363.00K | 361.00K |
| Total Assets | 26.73M | 29.32M | 28.23M | 28.57M | 27.87M |
|
|
|||||
| Total Accounts Payable | 16.97M | 17.91M | 15.14M | 15.09M | 10.24M |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | 14.19M | 7.58M | 8.88M | 12.13M | 3.94M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 20.52M | 21.46M | 21.90M | 22.35M | 16.85M |
| Total Finance Division Other Current Liabilities | 16.60M | 12.61M | 10.25M | 12.87M | 14.17M |
| Total Other Current Liabilities | 16.60M | 12.61M | 10.25M | 12.87M | 14.17M |
| Total Current Liabilities | 68.27M | 59.56M | 56.17M | 62.44M | 45.20M |
|
|
|||||
| Total Current Liabilities | 68.27M | 59.56M | 56.17M | 62.44M | 45.20M |
| Long-Term Debt | 28.30M | 24.47M | 20.43M | 10.22M | 20.31M |
| Short-term Debt | 14.19M | 7.58M | 8.88M | 12.13M | 3.94M |
| Capital Leases | 4.44M | 4.83M | 4.36M | 4.38M | 4.45M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 4.70M | 4.70M | 5.00M | 5.00M | 4.95M |
| Total Liabilities | 105.71M | 93.56M | 85.97M | 82.04M | 74.92M |
|
|
|||||
| Common Stock & APIC | 1.35B | 1.34B | 1.32B | 1.30B | 1.29B |
| Retained Earnings | -1.44B | -1.42B | -1.40B | -1.38B | -1.36B |
| Treasury Stock & Other | 2.96M | -108.00K | 2.15M | 2.07M | 1.46M |
| Total Common Equity | -94.49M | -80.12M | -76.50M | -73.28M | -65.77M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 15.51M | 15.88M | 18.75M | 19.81M | 18.72M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 15.51M | 15.88M | 18.75M | 19.81M | 18.72M |
|
|
|||||
| Total Common Equity | -94.49M | -80.12M | -76.50M | -73.28M | -65.77M |
| Total Preferred Equity | 15.51M | 15.88M | 18.75M | 19.81M | 18.72M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -78.98M | -64.24M | -57.74M | -53.47M | -47.06M |
|
|
|||||
